Case report describes levodopa's effect on parkinsonism in a patient with PPP2R5D neurodevelopmental disorder.
To describe a patient with intellectual disability and early-onset parkinsonism carrying a pathogenic de novo PPP2R5D variant.
No takes yet. Share an insight, caveat, or question.
Sarmiento et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: